for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

CVS Health Corp

CVS.N

Latest Trade

73.18USD

Change

-1.81(-2.41%)

Volume

1,590,467

Today's Range

72.64

 - 

75.00

52 Week Range

51.72

 - 

77.00

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Centene And CVS Health Announce Agreement For CVS Health To Acquire Illinicare Health

Dec 2 (Reuters) - CVS Health Corp <CVS.N>::CENTENE AND CVS HEALTH ANNOUNCE AGREEMENT FOR CVS HEALTH TO ACQUIRE ILLINICARE HEALTH.CVS HEALTH CORP - TRANSACTION ENTAILS SALE OF CENTENE'S MEDICAID AND MEDICARE ADVANTAGE LINES OF BUSINESS IN ILLINOIS..CVS HEALTH CORP - CENTENE WILL RETAIN ILLINICARE'S MEDICARE-MEDICAID ALIGNMENT INITIATIVE BUSINESS.CVS HEALTH CORP - CENTENE WILL RETAIN ILLINICARE'S STATEWIDE YOUTHCARE FOSTER CARE CONTRACT.CVS HEALTH CORP - CENTENE'S AMBETTER BUSINESS IN ILLINOIS IS NOT AFFECTED BY DEAL.CVS HEALTH CORP - CENTENE AND WELLCARE CONTINUE TO EXPECT THAT CENTENE - WELLCARE TRANSACTION WILL BE COMPLETED BY FIRST HALF OF 2020.CVS HEALTH CORP - FINANCIAL TERMS OF THIS TRANSACTION WILL NOT BE DISCLOSED.CVS HEALTH CORP - TRANSACTION IMPACT TO CVS HEALTH EARNINGS ONCE CLOSED IS EXPECTED TO BE IMMATERIAL..

Activist Investor Starboard Takes Stake in CVS - WSJ

Nov 25 (Reuters) - :ACTIVIST INVESTOR STARBOARD VALUE LP HAS TAKEN A STAKE IN CVS HEALTH CORP, HELD TALKS WITH THE DRUGSTORE-AND-INSURANCE GIANT'S MANAGEMENT - WSJ.

CVS Health Says Does Not Expect Reimbursement Pressures To Abate In 2020

Nov 6 (Reuters) - CVS Health Corp <CVS.N>::CVS HEALTH CORP SAYS HEALTH CARE BENEFITS UNIT WELL POSITIONED FOR GROWTH HEADING INTO 2020: CONF. CALL.CVS HEALTH CORP SAYS MADE DECISION TO CLOSE ABOUT 75 RETAIL PHARMACY STORES DURING 2020: CONF. CALL.CVS HEALTH CORP EXPECTS ITS MEDICAL BENEFIT RATIO FOR 2019 TO BE ABOVE MIDPOINT OF ITS FORECAST RANGE OF 84%.CVS HEALTH EXECUTIVE SAYS DOES NOT EXPECT REIMBURSEMENT PRESSURES TO ABATE IN 2020.

Ups And Cvs Make First Residential Drone Deliveries Of Prescription Medicines

Nov 5 (Reuters) - CVS Health Corp <CVS.N>::UPS AND CVS MAKE FIRST RESIDENTIAL DRONE DELIVERIES OF PRESCRIPTION MEDICINES.UPS - UPS AND CVS EXPLORING A VARIETY OF DRONE DELIVERY USE CASES.UPS - UPS FLIGHT FORWARD EXPANDING DRONE DELIVERY BEYOND HOSPITAL CAMPUSES.

CVS Says Removing 22 Ounce J&J Baby Powder From Stores

Oct 24 (Reuters) - CVS Health Corp <CVS.N>::CVS SAYS CVS PHARMACY IS COMPLYING WITH JOHNSON & JOHNSON’S VOLUNTARY RECALL OF JOHNSON’S BABY POWDER 22 OZ..CVS SAYS CVS PHARMACY IS REMOVING JOHNSON’S BABY POWDER 22 OZ. PRODUCT FROM ALL STORES AND FROM CVS.COM.CVS SAYS INITIATED “DO NOT SELL” REGISTER PROMPT IN STORES TO PREVENT SALE OF JOHNSON’S BABY POWDER 22 OZ. DURING PRODUCT REMOVAL PROCESS.CVS SAYS CUSTOMERS WHO PURCHASED JOHNSON’S BABY POWDER 22 OZ. PRODUCT FROM CVS PHARMACY SHOULD DISCONTINUE USE, AND CAN RETURN IT TO CVS FOR A REFUND.

CVS Health Sets Quarterly Dividend Of $0.50 Per Share

Oct 3 (Reuters) - CVS Health Corp <CVS.N>::SETS QUARTERLY DIVIDEND OF $0.50PER SHARE.

CVS Pharmacy Announced Collaboration With Google Photos On Their New Same-Day, Print-To-Store Experience

Sept 12 (Reuters) - CVS Pharmacy::CVS PHARMACY ANNOUNCED A COLLABORATION WITH GOOGLE PHOTOS ON THEIR NEW SAME-DAY, PRINT-TO-STORE EXPERIENCE.

CVS Health Says Seeing Additional Traffic And Sales Due To "HealthHUBs" - Conf. call

Aug 7 (Reuters) - CVS Health Corp <CVS.N>::CVS HEALTH EXPECTS TO DELIVER ABOUT $400 MILLION OF SYNERGY VALUE THIS YEAR; LARGEST CONTRIBUTOR TO OUT-PERFORMANCE IS FORMULARY OPTIMIZATION: CONF. CALL.CVS HEALTH CEO SAYS SEEING ADDITIONAL TRAFFIC, ADDITIONAL SALES IN THE PHARMACY AS WELL AS MINUTECLINIC BUSINESS DUE TO EXPANSION OF HEALTHHUBS.CVS HEALTH EXPECTS HEALTH CARE BENEFITS ADJUSTED OPERATING INCOME TO BE THE LOWEST FOR THE YEAR IN Q4 DUE TO THE CYCLICAL NATURE OF THAT BUSINESS.CVS HEALTH SAYS SEEING A "LITTLE BIT OF PRESSURE" IN MEDICAL COSTS FOR HEALTH INSURANCE BUSINESS, IN SELECT GEOGRAPHIES: CONF. CALL.

CVS Health Corp Sees FY Enterprise Consolidated Revenues $251.4 Billion To $254.2 Billion - Presentation

Aug 7 (Reuters) - CVS Health Corp <CVS.N>::SEES FY ENTERPRISE CONSOLIDATED REVENUES $251.4 BILLION TO $254.2 BILLION - PRESENTATION.SEES FY MEDICAL BENEFIT RATIO 84% PLUS OR MINUS 50 BPS.SUSPENSION OF HEALTH INSURER FEE IN 2019 WILL IMPACT CERTAIN OPERATING RATIOS.FY2019 REVENUE VIEW $252.59 BILLION -- REFINITIV IBES DATA."ENCOURAGED BY THE RECENT POLICY ADVANCEMENTS" WITH RESPECT TO WITHDRAWAL OF “REBATE RULE”."CONTINUE TO ADVOCATE FOR CHANGES THAT LOWER OUT OF POCKET COSTS FOR CONSUMERS ".

CVS Health Reports Second Quarter Results

Aug 7 (Reuters) - CVS Health Corp <CVS.N>::CVS HEALTH REPORTS SECOND QUARTER RESULTS.Q2 GAAP EARNINGS PER SHARE $1.49 FROM CONTINUING OPERATIONS.Q2 EARNINGS PER SHARE ESTIMATE $1.69 -- REFINITIV IBES DATA.SEES Q3 2019 ADJUSTED EARNINGS PER SHARE $1.75 TO $1.79.SEES FY 2019 ADJUSTED EARNINGS PER SHARE $6.89 TO $7.00.SEES Q3 2019 GAAP EARNINGS PER SHARE $1.16 TO $1.20 FROM CONTINUING OPERATIONS.SEES FY 2019 GAAP EARNINGS PER SHARE $4.93 TO $5.04 FROM CONTINUING OPERATIONS.2019 EPS GUIDANCE RAISED AND NARROWED.QTRLY REVENUES INCREASED 35.2% TO $63.4 BILLION.Q2 REVENUE VIEW $62.65 BILLION -- REFINITIV IBES DATA.QTRLY RETAIL/LTC SEGMENT TOTAL SAME STORE SALES ROSE 4.2%.QTRLY RETAIL/LTC SEGMENT FRONT STORE SAME STORE SALES ROSE 2.9%.Q3 EARNINGS PER SHARE VIEW $1.67 -- REFINITIV IBES DATA.CVS HEALTH QTRLY REVENUE GROWTH WAS DRIVEN BY AETNA DEAL, INCREASED VOLUME & BRAND NAME DRUG PRICE INFLATION IN PHARMACY SERVICES & RETAIL/LTC SEGMENTS.FY2019 EARNINGS PER SHARE VIEW $6.83 -- REFINITIV IBES DATA.QTRLY ADJUSTED EPS OF $1.89.RAISED 2019 CASH FLOW FROM OPERATIONS GUIDANCE RANGE TO $10.1 BILLION TO $10.6 BILLION.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up